Morgan Stanley analyst Tejas Savant maintained a Buy rating on 10x Genomics (TXG – Research Report) today and set a price target of $26.00. The company’s shares closed yesterday at $11.94.

Barclays lowered the firm’s price target on 10x Genomics (TXG) to $15 from $18 and keeps an Overweight rating on the shares. Published first on TheFly – the ultimate source for real-time ...

This is an executive interior configured for nine passengers. The cabin layout starts with a four club seat configuration, three place divan and dual aft berthable chairs all upholstered in gray ...

The Puma logo has been made more concise and more accessible over time. Its current form is smooth and contemporary, representing its namesake's swiftness and lightness. Maybe Reebok’s vector logo ...

In this article, we are going to take a look at where 10x Genomics, Inc. (NASDAQ:TXG) stands against the other stocks in Cathie Wood’s portfolio. Cathie Wood is one of Wall Street’s most ...

Camera: Excellent in all aspects, except for Selfie portrai t, normal selfies are superb and you will really like the AI skin tones. 10x zoom is great in good light conditions. just one small problem, ...

Discover the Top 20 best Fashion Logos that define style in the industry! From iconic to innovative, explore how these logos captivate audiences! In fashion, logos are more than just symbols; they are ...